Search Results 391-400 of 18863 for prostate cancer
Darolutamide is used to treat patients with non-metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical ...
Mayo Clinic is leading the way with a new treatment for advanced prostate cancer, specifically for prostate-specific membrane antigen-positive metastatic ...
Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience. Prostate Cancer Prostatic Dis. 2021 ...
... prostate cancer. The objectives are to describe the practice patterns of therapeutic agents for treatment of advanced prostate cancer internationally; to ...
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy · Overview · Participation ...
The prostate is a small gland in males that aids in reproduction. Prostate cancer is one the most common types of cancer, and when it's detected early ...
Prostate MRI. In the U.S., prostate cancer is the most common and second-most deadly noncutaneous cancer in men. But five-year survival rates approaching 100 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.